ReviewBiosensors2025
Opportunities and Challenges in Gas Sensor Technologies for Accurate Detection of COVID-19.
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Gas sensors provide versatile opportunities for detecting volatile organic compounds (VOCs) such as acetone, methanol, ethanol, propanol, isoprene, and aldehydes in exhaled breath (EB) associated with COVID-19 respiratory infections. These VOCs provide valuable information about metabolic markers linked with COVID-19. They have opened opportunities to develop sensors for COVID-19 screening based on breath analysis. These sensors have the potential to provide the rapid detection of viruses in healthcare settings. RT-PCR, as a conventionally adopted diagnostic method, has a detection limit around 10-100 RNA copies/mL, with an accuracy of around 95%. Gas sensors have demonstrated VOC detection limits at the ppm level in COVID-19 EB and have displayed a sensitivity and specificity of 98.2% and 74.3%, respectively. Multiple gas sensors combined with machine learning algorithms have the potential to enhance the specificity of VOC detection. In addition to having an accuracy similar to that of the PCR method, the VOC-based diagnosis of COVID-19 offers unique advantages in terms of non-invasive and rapid detection. This review provides an overview of state-of-the-art gas sensors developed for COVID-19 detection. Despite there being significant developments in this field, there are certain challenges that still need to be addressed-these include the impact of environmental factors, the specificity of detection, the sensing range, and precision limitations, leading to accuracy issues. Despite these existing challenges, the integration of gas sensors with machine learning methods can enhance the accuracy of the detection of COVID-19. Future research directions are proposed to validate and standardize the application of gas sensors for COVID-19 in clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.